1. Home
  2. Labeler Index
  3. Lupin Pharmaceuticals, Inc.
  4. 70748-346
  5. NDC Package Code: 70748-346-02 Liraglutide

NDC Package 70748-346-02 Liraglutide

Injection Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70748-346-02
Package Description:
2 SYRINGE, PLASTIC in 1 CARTON / 3 mL in 1 SYRINGE, PLASTIC
Product Code:
70748-346
Proprietary Name:
Liraglutide
Non-Proprietary Name:
Liraglutide
Substance Name:
Liraglutide
Usage Information:
This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite.
11-Digit NDC Billing Format:
70748034602
Product Type:
Human Prescription Drug
Labeler Name:
Lupin Pharmaceuticals, Inc.
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route(s):
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s):
LIRAGLUTIDE 6 mg/mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA215421
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
09-22-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
70748-346-033 SYRINGE, PLASTIC in 1 CARTON / 3 mL in 1 SYRINGE, PLASTIC

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70748-346-02?

The NDC Packaged Code 70748-346-02 is assigned to a package of 2 syringe, plastic in 1 carton / 3 ml in 1 syringe, plastic of Liraglutide, a human prescription drug labeled by Lupin Pharmaceuticals, Inc.. The product's dosage form is injection and is administered via subcutaneous form.

Is NDC 70748-346 included in the NDC Directory?

Yes, Liraglutide with product code 70748-346 is active and included in the NDC Directory. The product was first marketed by Lupin Pharmaceuticals, Inc. on September 22, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 70748-346-02?

The 11-digit format is 70748034602. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-270748-346-025-4-270748-0346-02